Skip to content
Screener

Guardant Health GH Price / book

Price / book at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
1.2×+0.1×
NeoGenomics logo
NeoGenomicsNEO
2.4×+1.3×
Illumina logo
IlluminaILMN
9.4×+3.0×
Veracyte logo
VeracyteVCYT
1.9×0.0×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
15.7×+7.4×
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
9.9×+4.1×

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$21.74B+294%
Enterprise value$22.34B+266%
P/S20.1×+13.5×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Calculated from Guardant Health’s reported figures.

Based on the most recent quarter.

The source filing: Guardant Health’s 10-Q, filed April 30, 2025. Open the filing →

Filed
Apr 30, 2025
Fiscal quarter
Q1 FY2025
Calendar quarter
Q1 2025
Accession
0001576280-25-000136

FAQ

What is Guardant Health's price / book?
Guardant Health (GH) reported price / book of 36.8× in Q1 2024.
What is the long-term trend for Guardant Health's price / book?
Over 3 years (2020 to 2023), Guardant Health's price / book has grown at a 27.0% compound annual growth rate (CAGR), from 10.1× to 20.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Guardant Health's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude